[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_3062 

# __Continue research and development of vaccines against sars-cov-2.__

## Category to which it belongs

* [Develop and promote vaccinations, prioritize vulnerable populations, improve access, and educate the public for global vaccine coverage.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_498.md)

## Closest similar item

* [Conduct research on the key factors contributing to the transmission of sars-cov-2.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3061.md)
* [Conduct research to understand the tissue tropism and pathogenesis of sars-cov-2.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3059.md)
* [Development and implementation of standardized protocols and assays for sars-cov-2 detection in environmental samples can ensure consistency and comparability of data.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2164.md)
* [Validate and optimize pcr assays to ensure accurate detection of sars-cov-2 genetic material.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3038.md)
* [Conduct comprehensive phylogenetic analysis to identify the original host animal of sars-cov-2.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3057.md)
* [Conduct research to determine the mechanisms of cell entry and membrane fusion of sars-cov-2.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3058.md)
* [Conduct more research and studies to gather sufficient evidence on the effectiveness of upper-room uvgi against sars-cov-2](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1621.md)
* [Improve specificity of pcr assays to distinguish between sars-cov-2 and other coronaviruses.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3039.md)
* [Development and implementation of validated methodological protocols for the quantitative analysis of sars-cov-2 in wastewater.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1600.md)
* [Reducing transmission routes of sars-cov-2](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_930.md)

## Risks possibly mitigated by this Mitigation

* [Expectations for vaccine](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_430.md)

